down arrow

Infant Bacterial Therapeutics AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0008015259
SEK
45.05
-1.4 (-3.01%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Swedish Orphan Biovitrum AB
Camurus AB
BioArctic AB
Swedencare AB
Calliditas Therapeutics AB
Egetis Therapeutics AB
Hansa Biopharma AB
Vicore Pharma Holding AB
Xspray Pharma AB
Infant Bacterial Therapeutics AB
FluoGuide A/S
Why is Infant Bacterial Therapeutics AB ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Infant Bacterial Therapeutics AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Infant Bacterial Therapeutics AB
3.8%
-0.67
82.42%
OMX Stockholm 30
8.01%
0.51
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-33.02%
EBIT to Interest (avg)
-122.51
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.25
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.50
EV to EBIT
-6.73
EV to EBITDA
-6.73
EV to Capital Employed
-16.60
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-76.16%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
RAW MATERIAL COST(Y)

Fallen by 0% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -124.91 %

OPERATING PROFIT(Q)

Highest at SEK -13.84 MM

PRE-TAX PROFIT(Q)

Highest at SEK -16.74 MM

NET PROFIT(Q)

Highest at SEK -16.74 MM

EPS(Q)

Highest at SEK -1.24

-5What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at SEK -116.34 MM

ROCE(HY)

Lowest at -58.41%

CASH AND EQV(HY)

Lowest at SEK 415.15 MM

Here's what is working for Infant Bacterial Therapeutics AB
Operating Profit
Highest at SEK -13.84 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Pre-Tax Profit
Highest at SEK -16.74 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK -16.74 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK -1.24
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Debt-Equity Ratio
Lowest at -124.91 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Infant Bacterial Therapeutics AB
Operating Cash Flow
Lowest at SEK -116.34 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Cash and Eqv
Lowest at SEK 415.15 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."